Development and validation of a method for simultaneous quantification of Clorhexidine and the preservative Nipazol in oral rinse by high performance liquid chromatography
Main Article Content
Abstract
This study has developed a method for simultaneous quantification of chlorhexidine and nipazole in oral rinse by reversed-phase HPLC. The method was performed on a C18 column (4.6 mm x 250 mm, 5 µm), using a mobile phase of a mixture of phosphate buffer pH 3.0 – acetonitrile with a gradient program. The injection volume was 50 µL. The UV detector was set at 256 nm. The developed method was validated for the requirements of specificity, system suitability, linearity, accuracy, precision (repeatability and intermediate precision) of both active ingredients and limit of quantification (LOQ) of nipazole according to ICH guidelines-(Q2R2). The validation results indicated that the developed procedure is suitable for the simultaneous quantification of chlorhexidine and nipazole in the oral rinse under study and can be applied in the laboratory.
Article Details
Keywords
Simultaneous quantification, chlorhexidine, nipazole, oral rinse, HPLC
References
2. Bộ Y tế (2018), Dược Điển Việt Nam V, NXB Y học.
3. European Pharmacopoeia Commission (2022), European Pharmacopoeia 11.
4. United States Pharmacopeial Convention (2025), The United States Pharmacopeia 2025.
5. Council of Europe, British Pharmacopoeia 2024.
6. World Health Organization (2022), Pharmacopoeia Internationalis 11th Edition.
7. Japan Pharmaceuticals and Medical Devices Agency (2021), Japanese Pharmacopoeia 18.
8. Nguyễn Thị Minh Đức, Nguyễn Huỳnh Kim Ngân, Nguyễn Thị Ngọc Vân (2019), “Xây dựng quy trình định lượng đồng thời chín paraben trong mỹ phẩm bằng phương pháp UPLC – đầu dò UV-VIS”, Tạp chí dược học, Tập 59, số 8 (2019) trang 76 - 80.
9. ICH (2023), Q2R2 Validation of Analytical Procedures.
10. AOAC (2016), Appendix F: Guidelines for Standard Method Performance Requirements.